This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
PPG Industries (PPG) to Display EV Battery Coatings in Michigan
by Zacks Equity Research
PPG Industries (PPG) will showcase its EV battery solutions portfolio at The Battery Show and Electric Vehicle & Hybrid Technology Expo.
Hawkins (HWKN) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Hawkins (HWKN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Ashland (ASH) Arm to Divest Performance Adhesives Unit to Arkema
by Zacks Equity Research
Ashland's (ASH) sale of its performance adhesives business to Arkema will enable it to be a dedicated additive and ingredients company, and a leader in life sciences, personal care and coatings.
US Specialty Chemical Volume Growth Speeds Up in July: 4 Picks
by Anindya Barman
U.S. specialty chemical volumes went up 1.1% in July as the industry continues its recovery. ASIX, HWKN, MTX and AGFS are worth betting on right now.
Zacks Industry Outlook Highlights: Element Solutions, Minerals Technologies, AdvanSix and Hawkins
by Zacks Equity Research
Zacks Industry Outlook Highlights: Element Solutions, Minerals Technologies, AdvanSix and Hawkins
4 Stocks to Watch From the Rebounding Chemical Specialty Industry
by Anindya Barman
The Zacks Chemicals Specialty industry is poised benefit from a rebound in global industrial and manufacturing activities. ESI, MTX, ASIX and HWKN are set to gain from demand recovery and strategic actions.
Why Hawkins (HWKN) Might be Well Poised for a Surge
by Zacks Equity Research
Hawkins (HWKN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Hawkins (HWKN) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 12.86% and 1.38%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Hawkins (HWKN) Q4 Earnings and Sales Surpass Estimates
by Zacks Equity Research
Higher consumer demand for health and immunity products drove sales in Hawkins' (HWKN) Health and Nutrition segment in Q4.
Hawkins (HWKN) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 65.38% and 8.36%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Hawkins (HWKN) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Hawkins (HWKN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Specialty Chemicals Stocks to Gain From Industry Turnaround
by Kaustav Ghosh
The global specialty chemicals industry seems poised to rebound on the gradual resumption of economic activities worldwide, making it prudent to invest in names like Kraton (KRA) and Hawkins (HWKN)
Hawkins (HWKN) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Hawkins (HWKN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Hawkins (HWKN) Beats Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 20.97% and 5.15%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Is Hawkins (HWKN) a Profitable Stock for Value Investors Now?
by Zacks Equity Research
Let's see if Hawkins (HWKN) stock is a good choice for value-oriented investors right now from multiple angles.
Looking for a Growth Stock? 3 Reasons Why Hawkins (HWKN) is a Solid Choice
by Zacks Equity Research
Hawkins (HWKN) could produce exceptional returns because of its solid growth attributes.
Are Investors Undervaluing Hawkins (HWKN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
This is Why Hawkins (HWKN) is a Great Dividend Stock
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Hawkins (HWKN) have what it takes? Let's find out.
Hawkins (HWKN) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Hawkins (HWKN) delivered earnings and revenue surprises of 3.60% and -0.08%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
US Chemical August Output Nudges Up on Manufacturing Strength
by Anindya Barman
U.S. chemical production expanded 0.6% in August as recovery gained steam in the manufacturing sector.
US Specialty Chemical Rebound Continues as August Volume Rises
by Anindya Barman
U.S. specialty chemicals market volumes ticked up 0.5% in August with most segments seeing growth.
5 Chemical Stocks to Snap Up on Global Manufacturing Revival
by Anindya Barman
With China seeing an economic rebound and manufacturing activities are improving around the world, things are looking up for the chemical industry.
US Chemical Output Ticks Up in July on Manufacturing Rebound
by Anindya Barman
U.S. chemical production expanded 0.8% in July as recovery strengthened in the manufacturing sector.
US Specialty Chemical Volumes Expand in July: 4 Top Picks
by Anindya Barman
The rebound in manufacturing activity and continued recovery in the U.S. economy are likely to act as a tailwind for the U.S. specialty chemical industry.